Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics

Eunji Cho, Gi Hoon Nam, Yeonsun Hong, Yoon Kyoung Kim, Dong-Hwee Kim, Yoosoo Yang, In-San Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Exosomes are small membrane vesicles secreted by most cell types that play an important role in intercellular communication. Due to the characteristic of transferring their biomacromolecules, exosomes have potential as a new alternative for delivering protein therapeutics. Here, we investigate whether exosomes provide crucial advantages over other nanoparticles, in particular protein nanocage formulations, as a delivery system for membrane protein therapeutics. We characterized membrane-scaffold–based exosomes and protein-scaffold–based ferritin nanocages, both harboring SIRPα (signal regulatory protein α), an antagonist of CD47 on tumor cells. The efficacy of these two systems in delivering protein therapeutics was compared by testing their ability to enhance phagocytosis of tumor cells by bone-marrow–derived macrophages and subsequent inhibition of in vivo tumor growth. These analyses allowed us to comprehensively conclude that the therapeutic index of exosome-mediated CD47 blockade against tumor growth inhibition was higher than that of the same dose of ferritin-SIRPα. The results of this analysis reveal the importance of the unique characteristics of exosomes, in particular their membrane scaffold, in improving therapeutic protein delivery compared with protein-scaffold–based nanocages.

Original languageEnglish
Pages (from-to)326-335
Number of pages10
JournalJournal of Controlled Release
Volume279
DOIs
Publication statusPublished - 2018 Jun 10

Fingerprint

Exosomes
Ferritins
Membrane Proteins
Proteins
Therapeutics
Membranes
Neoplasms
Cytophagocytosis
Growth
Nanoparticles
Macrophages
Bone and Bones

Keywords

  • CD47
  • Exosome
  • Ferritin nanocages
  • Membrane protein therapeutics
  • SIRPα

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics. / Cho, Eunji; Nam, Gi Hoon; Hong, Yeonsun; Kim, Yoon Kyoung; Kim, Dong-Hwee; Yang, Yoosoo; Kim, In-San.

In: Journal of Controlled Release, Vol. 279, 10.06.2018, p. 326-335.

Research output: Contribution to journalArticle

Cho, Eunji ; Nam, Gi Hoon ; Hong, Yeonsun ; Kim, Yoon Kyoung ; Kim, Dong-Hwee ; Yang, Yoosoo ; Kim, In-San. / Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics. In: Journal of Controlled Release. 2018 ; Vol. 279. pp. 326-335.
@article{91038d88e4f5477aaafe42f961d07043,
title = "Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics",
abstract = "Exosomes are small membrane vesicles secreted by most cell types that play an important role in intercellular communication. Due to the characteristic of transferring their biomacromolecules, exosomes have potential as a new alternative for delivering protein therapeutics. Here, we investigate whether exosomes provide crucial advantages over other nanoparticles, in particular protein nanocage formulations, as a delivery system for membrane protein therapeutics. We characterized membrane-scaffold–based exosomes and protein-scaffold–based ferritin nanocages, both harboring SIRPα (signal regulatory protein α), an antagonist of CD47 on tumor cells. The efficacy of these two systems in delivering protein therapeutics was compared by testing their ability to enhance phagocytosis of tumor cells by bone-marrow–derived macrophages and subsequent inhibition of in vivo tumor growth. These analyses allowed us to comprehensively conclude that the therapeutic index of exosome-mediated CD47 blockade against tumor growth inhibition was higher than that of the same dose of ferritin-SIRPα. The results of this analysis reveal the importance of the unique characteristics of exosomes, in particular their membrane scaffold, in improving therapeutic protein delivery compared with protein-scaffold–based nanocages.",
keywords = "CD47, Exosome, Ferritin nanocages, Membrane protein therapeutics, SIRPα",
author = "Eunji Cho and Nam, {Gi Hoon} and Yeonsun Hong and Kim, {Yoon Kyoung} and Dong-Hwee Kim and Yoosoo Yang and In-San Kim",
year = "2018",
month = "6",
day = "10",
doi = "10.1016/j.jconrel.2018.04.037",
language = "English",
volume = "279",
pages = "326--335",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Comparison of exosomes and ferritin protein nanocages for the delivery of membrane protein therapeutics

AU - Cho, Eunji

AU - Nam, Gi Hoon

AU - Hong, Yeonsun

AU - Kim, Yoon Kyoung

AU - Kim, Dong-Hwee

AU - Yang, Yoosoo

AU - Kim, In-San

PY - 2018/6/10

Y1 - 2018/6/10

N2 - Exosomes are small membrane vesicles secreted by most cell types that play an important role in intercellular communication. Due to the characteristic of transferring their biomacromolecules, exosomes have potential as a new alternative for delivering protein therapeutics. Here, we investigate whether exosomes provide crucial advantages over other nanoparticles, in particular protein nanocage formulations, as a delivery system for membrane protein therapeutics. We characterized membrane-scaffold–based exosomes and protein-scaffold–based ferritin nanocages, both harboring SIRPα (signal regulatory protein α), an antagonist of CD47 on tumor cells. The efficacy of these two systems in delivering protein therapeutics was compared by testing their ability to enhance phagocytosis of tumor cells by bone-marrow–derived macrophages and subsequent inhibition of in vivo tumor growth. These analyses allowed us to comprehensively conclude that the therapeutic index of exosome-mediated CD47 blockade against tumor growth inhibition was higher than that of the same dose of ferritin-SIRPα. The results of this analysis reveal the importance of the unique characteristics of exosomes, in particular their membrane scaffold, in improving therapeutic protein delivery compared with protein-scaffold–based nanocages.

AB - Exosomes are small membrane vesicles secreted by most cell types that play an important role in intercellular communication. Due to the characteristic of transferring their biomacromolecules, exosomes have potential as a new alternative for delivering protein therapeutics. Here, we investigate whether exosomes provide crucial advantages over other nanoparticles, in particular protein nanocage formulations, as a delivery system for membrane protein therapeutics. We characterized membrane-scaffold–based exosomes and protein-scaffold–based ferritin nanocages, both harboring SIRPα (signal regulatory protein α), an antagonist of CD47 on tumor cells. The efficacy of these two systems in delivering protein therapeutics was compared by testing their ability to enhance phagocytosis of tumor cells by bone-marrow–derived macrophages and subsequent inhibition of in vivo tumor growth. These analyses allowed us to comprehensively conclude that the therapeutic index of exosome-mediated CD47 blockade against tumor growth inhibition was higher than that of the same dose of ferritin-SIRPα. The results of this analysis reveal the importance of the unique characteristics of exosomes, in particular their membrane scaffold, in improving therapeutic protein delivery compared with protein-scaffold–based nanocages.

KW - CD47

KW - Exosome

KW - Ferritin nanocages

KW - Membrane protein therapeutics

KW - SIRPα

UR - http://www.scopus.com/inward/record.url?scp=85046358597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046358597&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2018.04.037

DO - 10.1016/j.jconrel.2018.04.037

M3 - Article

C2 - 29679665

AN - SCOPUS:85046358597

VL - 279

SP - 326

EP - 335

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -